Canton Strategic Holdings Sells Gravitas Life Sciences for $3.5M Note

What Happened

• Canton Strategic Holdings, Inc. announced on July 17, 2026 that it completed the sale of all issued and outstanding membership interests of its clinical‑stage subsidiary Gravitas Life Sciences, LLC to Gravitas Collective Corp. The Transaction closed July 17, 2026 after Gravitas was converted to an LLC on July 16, 2026.
• As consideration, Canton received an unsecured promissory note with an original principal of $3,500,000 (the "Gravitas Note") and agreed‑upon contingent development milestone payments. The company issued a press release on July 23, 2026 announcing the closing.

Key Details

• Purchase consideration: $3,500,000 unsecured promissory note (Gravitas Note); interest 15% per annum, payable in kind (PIK), compounding semi‑annually; maturity date July 17, 2029.
• Buyer affiliation: Gravitas Collective Corp. is affiliated with former Canton directors Vincent LoPriore, Sireesh Appajosyula and Gary Stetz; Canton formed a special committee of independent, non‑interested directors to review and approve the Transaction.
• Asset carve‑out: Canton retained certain Gravitas assets related to bispecific antibody development through its subsidiary Tharimmune SPV1 under a Bill of Sale, Assignment and Assumption Agreement.
• Additional steps: Canton entered release agreements with certain individuals in connection with the Transaction; the Transaction includes mandatory and optional prepayment provisions for the Gravitas Note.

Why It Matters

• The deal removes a clinical‑stage unit from Canton’s direct operations while replacing it with a $3.5M receivable that carries a high PIK interest rate and potential milestone upside, which affects Canton’s near‑term cash flow and long‑term recovery prospects.
• Related‑party affiliation and the use of a special committee are material governance points investors should note; repayment depends on the buyer/Gravitas performance and optional prepayments, so the promissory note is not equivalent to cash on hand.
• Canton filed pro forma financial information and a press release with the SEC in connection with the closing, which investors can review for estimated financial impacts.